Innovation1 Biotech Inc. Quarterly Operating Income (Loss) in USD from Q4 2017 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Innovation1 Biotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2017 to Q3 2023.
Innovation1 Biotech Inc. Operating Income (Loss) for the quarter ending August 31, 2023 was $201K.
Innovation1 Biotech Inc. Operating Income (Loss) for the twelve months ending August 31, 2023 was -$1.37M, a 74% increase year-over-year.
Innovation1 Biotech Inc. annual Operating Income (Loss) for 2023 was -$1.37M, a 74% increase from 2022.
Innovation1 Biotech Inc. annual Operating Income (Loss) for 2022 was -$5.25M, a 1931% decline from 2021.
Innovation1 Biotech Inc. annual Operating Income (Loss) for 2021 was -$258K, a 19.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	-$1.37M	$201K	+$1.71M		Jun 1, 2023	Aug 31, 2023	10-K	2024-01-17
Q2 2023	-$3.08M	-$204K	+$1.39M	+87.2%	Mar 1, 2023	May 31, 2023	10-Q	2023-09-13
Q1 2023	-$4.47M	-$736K	+$1.05M	+58.7%	Dec 1, 2022	Feb 28, 2023	10-Q	2023-05-30
Q4 2022	-$5.52M	-$629K	-$268K	-74.2%	Sep 1, 2022	Nov 30, 2022	10-Q	2023-01-17
Q3 2022	-$5.25M	-$1.51M	-$1.41M	-1443%	Jun 1, 2022	Aug 31, 2022	10-K	2024-01-17
Q2 2022	-$3.84M	-$1.6M	-$1.55M	-3287%	Mar 1, 2022	May 31, 2022	10-Q	2023-09-13
Q1 2022	-$2.29M	-$1.78M	-$1.73M	-3067%	Dec 1, 2021	Feb 28, 2022	10-Q	2023-05-30
Q4 2021	-$562K	-$361K	-$304K	-532%	Sep 1, 2021	Nov 30, 2021	10-Q	2023-01-17
Q3 2021	-$258K	-$97.9K	-$33.6K	-52.4%	Jun 1, 2021	Aug 31, 2021	10-K	2022-12-15
Q2 2021	-$225K	-$47.1K	+$2.25K	+4.57%	Mar 1, 2021	May 31, 2021	10-Q	2022-07-14
Q1 2021	-$227K	-$56.3K	-$8.22K	-17.1%	Dec 1, 2020	Feb 28, 2021	10-Q	2022-04-15
Q4 2020	-$219K	-$57.2K	-$1.96K	-3.54%	Sep 1, 2020	Nov 30, 2020	10-Q/A	2022-02-01
Q3 2020	-$217K	-$64.3K	+$73.3K	+53.3%	Jun 1, 2020	Aug 31, 2020	10-K	2021-12-10
Q2 2020	-$290K	-$49.4K	+$93.9K	+65.6%	Mar 1, 2020	May 31, 2020	10-Q	2021-07-13
Q1 2020	-$384K	-$48.1K	+$106K	+68.9%	Dec 1, 2019	Feb 29, 2020	10-Q	2021-04-14
Q4 2019	-$490K	-$55.2K	+$136K	+71.2%	Sep 1, 2019	Nov 30, 2019	10-Q	2021-01-13
Q3 2019	-$627K	-$138K	+$135K	+49.6%	Jun 1, 2019	Aug 31, 2019	10-K	2020-12-15
Q2 2019	-$762K	-$143K	-$124K	-660%	Mar 1, 2019	May 31, 2019	10-Q	2020-07-20
Q1 2019	-$638K	-$154K	-$32.5K	-26.7%	Dec 1, 2018	Feb 28, 2019	10-Q	2020-04-20
Q4 2018	-$605K	-$192K	-$169K	-745%	Sep 1, 2018	Nov 30, 2018	10-Q	2020-01-21
Q3 2018	-$436K	-$273K			Jun 1, 2018	Aug 31, 2018	10-K	2019-12-17
Q2 2018		-$18.8K			Mar 1, 2018	May 31, 2018	10-Q	2019-07-18
Q1 2018		-$122K			Dec 1, 2017	Feb 28, 2018	10-Q	2019-04-15
Q4 2017		-$22.7K			Sep 1, 2017	Nov 30, 2017	10-Q	2019-01-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.